24 hours of full access, free. No credit card.
Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 anticipated to...
This is the newest page. Registered accounts read further back.